1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60C38C326D5AF805485256E35007346CF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/patient-advocacy-professional-relations-research-bundle?opendocument
18
19opendocument
20107.23.176.162
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing Marketing Management Professional and Patient Advocacy Relations

Patient Advocacy & Professional Relations Research Bundle

DB Image

ID: 4552


Features:

Metrics, Graphics


Pages/Slides: 11,395


Published: Pre-2013


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

Save 26% with this value bundle!

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
  • INCLUDED RESEARCH
A comprehensive introduction to the value that strong relationships with patient advocacy groups bring to pharmaceutical companies. This document bundles several database documents, including 4262, 4265, 4431 and 3626 – spanning three separate research initiatives from Best Practices LLC. Topics covered include how companies select patient advocacy groups and organize activities with them. Documents show examples of when relationships with patient advocacy groups can help further a company’s efforts such as in communicating the results of clinical trials and in assisting with drug development efforts. Case studies also detail lessons learned from past patient advocacy partnerships. The information in this document will help readers understand pharmaceutical industry best practices for working with patient advocacy groups.

Industries Profiled:
Pharmaceutical; Biotech; Health Care; Medical Device


Companies Profiled:
A Leading Pharmaceutical Company; Sanofi-aventis; Abbott Laboratories; AstraZeneca; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly; Eli Lilly and Company; GlaxoSmithKline; Janssen; Merck; Novartis; Pfizer; Pharmacia; Roche; Schering-Plough


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

This bundle combines all of the individual research listed below into one easy-to-purchase transaction. Read individual research abstracts by clicking the titles. Return to this page to add the bundle to your cart.



Why purchase a bundle?
Purchasing this research together provides you with significant savings over the individual research price. In addition to the reduced price, you’ll also experience ease of use. After purchase, previous and next buttons will direct you sequentially through the research findings. If you have additional questions, please call us at (919) 403-0251.